Hydroxyurea induces the gene expression and synthesis of proinflammatory cytokines in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 477-482

  Navarra, Pierluigi ^a   Grohmann, Ursula ^b   Nocentini, Giuseppe ^b   Tringali, Giuseppe ^a   Puccetti, Paolo ^c   Riccardi, Carlo ^b   Preziosi, Paolo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CYTOKINE; GAMMA INTERFERON; HYDROXYUREA; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; GENE INDUCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; SPLEEN CELL;

ADRENALECTOMY; ANIMALS; ANTINEOPLASTIC AGENTS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; GENE EXPRESSION REGULATION; HYDROXYUREA; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030968546     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ARGENTINO-STORINO, A., NUNZIATA, A., NAVARRA, P. AND PREZIOSI, P.: A histopathological study on the causes of increased lethality induced by hydroxyurea in hypophysectomized rats (Abstract). Toxicol. Lett. P40/P3, suppl., p.317, 1992.
2. BERNARDINI, H., KAMILARIS, T. C., CALOGERO, A. E., JOHNSON, E. O., GOMEZ, M. T., GOLD, P. W. AND CHROUSOS, G. P.: Interactions between tumor necrosis factor-α, hypothalamic corticotropin-releasing hormone and adrenocorticotropin secretion in the rat. Endocrinology 126: 2876-2881, 1990.
3. BERTINI, R., BIANCHI, M. AND GHEZZI, P.: Adrenalectomy sensitizes mice to the lethal effects of interleukin-1 and tumor necrosis factor. J. Exp. Med. 167: 1708-1712, 1988.
4. BEYAERT, R., VANHAESEBROECK, B., SUFFYS, P., VAN ROY, F. AND FIERS, W.: Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 86: 9494-9498, 1989.
5. BUSBRIDGE, N. J. AND GROSSMAN, A.: Stress and the single cytokine: Interleukin modulation of the pituitary-adrenal axis. Mol. Cell. Endocrinol. 82: C209-C214, 1992.
6. CAMPANILE, F., GIANPIETRI, A., GROHMANN, U., BINAGLIA, L., FIORETTI, M. C. AND PUCCETTI, P.: Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection in neutropenic mice, Cell. Immunol. 147: 341-352, 1993.
7. CAMPANILE, F., GROHMANN, U., GIANPIETRI, A., BELLADONNA, L., FIORETTI, M. C. AND PUCCETTI, P.: Cytokine expression in experimental Gram-negative infection. Fund. Clin. Immunol. 2: 97-99, 1994.
8. CHABNER, B. A., ALLEGRA, C. J., CURT, G. A. AND CALABRESI, P.: Antineoplastic agents. In Goodman and Gilman's The pharmacological Basis of Therapeutics, 9th ed., ed. by J. G. Hardman, L. E., Limbird, P. B., Molinoff, R. W., Ruddon and A. Goodman Gilman, pp. 1233-1287. McGraw-Hill Companies, Inc., 1996.
9. CHROUSOS, G. P.: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1362, 1995.
10. CIDLOWSKI, J. A. AND CIDLOWSKI, N. B.: Glucocorticoid receptors and the cell cycle: Evidence that the accumulation of glucocorticoid receptors during the S phase of the cell cycle is dependent on ribonucleic acid and protein synthesis. Endocrinology 110: 1653-1662, 1982.
11. DAYNES, R. A. AND ARANEO, B. A.: Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin-2 and interleukin-4. Eur. J. Immunol. 19: 2319-2325, 1989.
12. DINARELLO, C. A.: Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991.
13. ESPEVIK, T. AND NISSEN-MEYER, J.: A highly sensitive cell line, WEHI 164 clone 13, for measuring citotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95: 99-105, 1986.
14. ESSNER, R., RHOADES, K. MCBRIDE, W. H., MORTON, D. L. AND ECONOMOU, J. S.: IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J. Immunol. 142: 3857-3861, 1989.
15. FERRUA, B., MANIE, S., DOGLIO, A., SHAW, A., SONTHONNAX, S., LIMOUSE, M. AND SCHAFFER, L.: Stimulation of human interleukin-1 production and specific mRNA expression by microtubule-disrupting agents. Cell. Immunol. 131: 391-397, 1990.
16. KOENIG, J. I.: Presence of cytokines in the hypothalamic-pituitary axis. Prog. NeuroEndocrinImmunol. 4: 143-153, 1991.
17. KOVACS, E. J., OPPENHEIM, J. J., CARTER, D. B. AND YOUNG, H. A.: Enhanced interleukin-1 production by human monocyte cell lines following treatment with 5-azacytidine. J. Leukoc. Biol. 41: 40-46, 1987.
18. LITTLEFIELD, B. A., HOAGLAND, H. C. AND GREIPP, P. R.: Elevated glucocorticoid receptor binding in cultured human lymphoblasts following hydroxyurea treatment: Lack of effect on steroid responsiveness. Cancer Res. 46: 3945-3950, 1986.
19. LORI, F., MALYKH, A., CARA, A., SUN, D., WEINSTEIN, J. N., LISZIEWICZ, J., GALLO, R. C.: Hydroxyurea as an inhibitor of human immunodeficiency virus-type I replication. Science (Wash. D.C.) 266: 801-805, 1994.
20. MATSUSHIMA, K., COPELAND, T. D., ONOZAKI, K. AND OPPENHEIM, J. J.: Purification and biochemical characteristics of two distinct human interleukins 1 from myelomonocytic THP-1 cell line. Biochemistry 25: 3424-3429, 1986.
21. MCBRIDE, W. H., HOON, D. B., JUNG, T., NAUNGAYAN, J., NIZZE, A. AND MORTON, D. L.: Cyclophosphamide-induced alterations in human monocyte functions. J. Leukoc. Biol. 42: 659-666, 1987.
22. MORGAN, J. S., CREASEY, D. C. AND WRIGHT, J. A.: Evidence that the antitumor agent hydroxyurea enters mammalian cells by a diffusion mechanism. Biochem. Biophys. Res. Commun. 134: 1254-1259, 1986.
23. NAVARRA, P., DEL CARMINE, R., CIABATTONI, G., D'AMATO, M., RAGAZZONI, E., VACCA, M., VOLPE, A. R. AND PREZIOSI, P.: Hydroxyurea: Relationship between centrally-induced adrenal activation and toxicity. Pharmacol. and Toxicol. 67: 209-215, 1990.
24. NAVARA, P., TRINGALI, G. AND PREZIOSI, P.: The effects of inhibitors of cyclooxygenase, lipoxigenase and nitric oxide synthese pathways on the toxicity of hydroxyurea in adrenalectomized rats. Toxicol. Lett. 86: 13-18, 1996.
25. NAVARRA, P., TSAGARAKIS, S., FARIA, M. S., REES, L. H., BESSER, G. M. AND GROSSMAN, A. B.: Interleukinss-l and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128: 37-44, 1991.
26. NOCENTINI, G.: Ribonucleotide reductase inhibitors: New strategies for cancer chemotherapy. Crit. Rev. Oncol. Hematol. 22: 89-126, 1996.
27. POMEAU-DELILLE, G.: Techniques biologiques en endocrinologie expérimentale chez le rat. Masson, Paris. 1953.
28. PREZIOSI, P., PARENTE, L. AND NAVARRA, P.: Cytokines and eicosanoids in cancer drug toxicity. Trends in Pharmacol. Sci. 13: 226-229, 1992.
29. RYFFEL, B.: Role of proinflammatory cytokines in a toxin response: Application of cytokine knockout mice in toxicological research. Toxicol. Lett. 82/83: 477-482, 1995.
30. SAPOLSKY, R., RIVIER, C., YAMAMOTO, G., PLOTSKY, P. AND VALE, V.: Interleukin-l stimulates the secretion of hypothalamic corticotrophin-releasing factor. Science 233: 522-524, 1987.
31. SUWABE, A., TAKAHASHI, K., YASUI, S., ARAI, S. AND SENDO, F.: Bleomycin-stimulated hamster alveolar macrophages release interleukin-1. Am. J. Pathol. 132: 512-520, 1988.
32. TOMITA, K. AND PLACER, J. E.: In vivo cell cycle synchronization of the murine sarcoma 180 tumor following alternating periods of hydroxyurea blockade and release. Cancer Res. 39: 4407-441, 1979.
33. VACCA, M. AND PREZIOSI, P.: Tolerance to pituitary adrenal axis activation by anticancer drugs. Arch. Toxicol. Suppl. 7: 98-102, 1984.
34. TE VELDE, A. A., HUIJBENS, R. J. F., HEIJE, K., DE VRIES, J. E. AND FIGDOR, C. G.: Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α, and IL-6 by human monocytes. Blood 76: 1392-1397, 1990.
35. VOLPE, A. R., NAVARRA, P. AND PREZIOSI, P.: Blood and brain hydroxyurea levels: Relationship with adrenocortical activation. Arch. Int. Pharmacodyn. Ther 298: 302-303, 1989.